Mysimba is a prescription medication used primarily for weight management in adults with additional weight-related health conditions. It is a combination of two active ingredients, naltrexone hydrochloride and bupropion hydrochloride, which work together to reduce hunger and control cravings. Naltrexone is typically used to manage alcohol and opioid dependence, while bupropion is often prescribed for depression and to help with smoking cessation. When combined in Mysimba, these substances target the central nervous system to help patients achieve and maintain weight loss as part of a comprehensive treatment plan that includes diet, exercise, and lifestyle modification. It is important for patients to follow their healthcare provider's instructions closely when taking Mysimba, as it may not be suitable for everyone and can have potential side effects.